| Literature DB >> 32868223 |
Kemal Koray Bal1, Murat Unal2, Nuran Delialioglu3, Ragip Onur Oztornaci4, Onur Ismi2, Yusuf Vayisoglu2.
Abstract
INTRODUCTıON: Deep neck infections are a group of diseases with serious complications and mortality, which can occur as a result of common diseases in the community and which have surgical and medical treatment options.Entities:
Keywords: Anaerobic bacteria; Antibiotics; Deep neck infections; Mortality; Surgery
Mesh:
Substances:
Year: 2020 PMID: 32868223 PMCID: PMC9422577 DOI: 10.1016/j.bjorl.2020.07.002
Source DB: PubMed Journal: Braz J Otorhinolaryngol ISSN: 1808-8686
Physical examination findings.
| Physical examination | Frequency | Percentages |
|---|---|---|
| Groups | ||
| Parotid swelling | 4 | 5.4 |
| Submandibular swelling | 20 | 27.0 |
| The medial of SCM (Sternocleidomastoid Muscle) swelling | 7 | 9.5 |
| The posterior cervical triangle swelling | 2 | 2.7 |
| Submental swelling | 4 | 5.4 |
| Mandibular swelling (mandibular corpus) | 1 | 1.4 |
| Bulging in the upper pole of the tonsil and pushing in the uvula | 31 | 41.9 |
| Swelling in Submandibular + SCM medial + Posterior cervical triangle | 1 | 1.4 |
| Submandibular + Parotid swelling | 1 | 1.4 |
| Bulging in the upper pole of the tonsil and pushing in the uvula + Submandibular swelling | 1 | 1.4 |
| Submandibular + SCM medial swelling | 2 | 2.7 |
Aerobic bacteria.
| Aerobic bacteria | Frequency | Percentages |
|---|---|---|
| Groups | ||
| Methicillin Resistant Staphylococcus Aureus (MRSA) | 3 | 6.5 |
| Klebsiella pneumoniae | 2 | 4.3 |
| 16 | 34.7 | |
| Escherichia coli | 1 | 2.1 |
| Methicillin Sensitive Coagulase Negative Staphylococcus (MSCNS) | 11 | 23.9 |
| Non A Non B Group Beta Hemolytic Streptococcus | 2 | 4.3 |
| Brucella Melitensis | 1 | 2.1 |
| Methicillin Sensitive Staphylococcus Aureus (MSSA) | 3 | 6.5 |
| Streptococcus pyogenes | 1 | 2.1 |
| Methicillin Resistant Coagulase Negative Staphylococcus (MRCNS) | 3 | 6.5 |
| Streptococcus mitis/oralis (alpha hemolytic streptococcus) | 1 | 2.1 |
| Streptococcus pneumoniae | 1 | 2.1 |
| Mycobacterium tuberculosis | 1 | 2.1 |
Abscess locations.
| Abscess locations | Frequency | Percentages | |
|---|---|---|---|
| Groups | Level 5 | 2 | 2.7 |
| Parapharyngeal | 10 | 13.5 | |
| Peritonsilllar | 30 | 40.5 | |
| Submandibular | 10 | 13.5 | |
| Medial of SCM | 9 | 12.2 | |
| Parotid Space | 2 | 2.7 | |
| Submental | 4 | 5.4 | |
| Peritonsillar + Parapharyngeal | 2 | 2.7 | |
| Submandibular + Medial of SCM + Level 5 | 1 | 1.4 | |
| Submandibular + Parapharyngeal | 1 | 1.4 | |
| Submandibular + Medial of SCM | 3 | 4.1 | |
Etiology of infections.
| Etiology of infections | Frequency | Percentages | |
|---|---|---|---|
| Groups | Folliculitis (nape skin) | 1 | 1.4 |
| Parotitis | 2 | 2.7 | |
| Infected branchial cyst | 2 | 2.7 | |
| Lymphadenitis | 6 | 8.1 | |
| Tonsillopharyngitis | 38 | 51.4 | |
| Odontogenic Infection | 20 | 27.0 | |
| Nasopharyngitis | 2 | 2.7 | |
| Submandibular gland sialoadenitis | 2 | 2.7 | |
| Tonsillopharyngitis + Odontogenic infection | 1 | 1.4 | |
| Total | 74 | 100.0 | |
Empirical antibiotic therapy.
| Empirical antibiotic | Frequency | Percentages | |
|---|---|---|---|
| Groups | Clindamycin | 6 | 8.1 |
| Ampicillin + Sulbaktam | 12 | 16.2 | |
| Ertapenem | 1 | 1.4 | |
| Sultamicillin | 3 | 4.1 | |
| Cefazolin | 1 | 1.4 | |
| Meropenem + Teicoplanin | 1 | 1.4 | |
| Clindamycin + Ciprofloxacin + Anidulafungin | 1 | 1.4 | |
| Ampicillin + Sulbaktam + Clindamycin | 49 | 66.2 | |
Bacterial growth status in patients.
| Bacterial growth status in patients | Frequency | Percentages | |
|---|---|---|---|
| Groups | Aerobic + Anaerobic (mixed, polymicrobial) | 12 | 20.0 |
| Aerobic | 29 | 48.3 | |
| Anaerobic | 10 | 16.7 | |
| No bacterial growth | 9 | 15.0 | |
Anaerobic bacteria.
| Anaerobic Bacteria | Frequency | Percentages | |
|---|---|---|---|
| Groups | Peptostreptococcus spp. | 5 | 18.5 |
| Prevotella spp. | 5 | 18.5 | |
| Prevotella oralis | 5 | 18.5 | |
| Veillonella spp. | 1 | 3.7 | |
| Porphyromonas spp. | 1 | 3.7 | |
| Campylobacter uratolytic (Bacteroides uratolytic) | 2 | 7.4 | |
| 1 | 3.7 | ||
| Prevotella intermedia | 4 | 14.8 | |
| Fusobacterium nucleatum | 1 | 3.7 | |
| Prevotella melaninogenica | 1 | 3.7 | |
| Porphyromonas endotalis | 1 | 3.7 | |